FDA identifies Avanos Medical’s Cortrak* 2 EAS recall as Class I
Avanos Medical recalled Cortrak* 2 EAS following reports of injuries and patient deaths due to tube misplacements.
Business & Regulation
Latest in
Business & Regulation
Medtronic concludes Intersect ENT acquisition
The deal adds Intersect ENT's PROPEL and SINUVA sinus implant product lines and technology to Medtronic's portfolio.
Cepheid secures FDA EUA for rapid Covid-19 diagnostic test
Xpert Xpress CoV-2 plus is a rapid molecular diagnostic test designed to identify Covid-19 causing virus.
BD reports 2.1% increase in Q1 2022 revenues
The company’s net income in the quarter jumped 51.7% Y-o-Y to $454m.
Quidel’s quarterly revenues more than double to $1bn in Q1 2022
In the same quarter a year ago, the company reported revenues of $375.3m.
Thermo Fisher Scientific reports 19% rise in quarterly revenue
The company reported revenues of $11.82bn for the first quarter of 2022.
Boston Scientific reports net sales of $3.03bn in Q1 2022
The company also reorganised its operations into two reportable segments during the quarter.
Philips reports group sales of $4.17bn in Q1 2022
Philips’ loss from continuing operations widened to €152m in the quarter.